GenomePrecision Funding: $45M Raised, Series C (2021)
GenomePrecision is based in Beijing, China. It has raised $45M in total funding. Latest round: Series C.
GenomePrecision funding overview
GenomePrecision is based in Beijing, China. GenomePrecision has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in April 2021. The round record for GenomePrecision runs through 2021; nothing later has been disclosed. Investors on record include Sunland Fund, ZGC Co-Innovation Fund, Yinhe Yuanhui Investment, Guiyang Venture Capital, Zhejiang Juren Capital, Oriental Fortune Capital. 6 distinct backers are named across the disclosed rounds.
GenomePrecision has raised $45M in total disclosed funding across the rounds on record.
Who has invested in GenomePrecision?
Sunland Fund, ZGC Co-Innovation Fund, Yinhe Yuanhui Investment, Guiyang Venture Capital, Zhejiang Juren Capital, Oriental Fortune Capital are named among the investors backing GenomePrecision.
What was the latest GenomePrecision funding round?
The most recent disclosed round is a Series C, announced in April 2021.
Where is GenomePrecision based?
GenomePrecision is based in Beijing, China.
When did GenomePrecision last raise?
The last disclosed GenomePrecision round closed in April 2021 at Series C.
Every GenomePrecision figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Beijing at a similar stage.
